Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Clin Cardiol Retrieve available abstracts of 147 articles: HTML format

Single Articles

September 2022
1. IVEY SL, Hanley HR, Taylor C, Stock E, et al
   Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
   Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
   PubMed     Abstract available
   
   
   
2. SHAIK A, Kosiborod M, de Lemos JA, Gao Q, et al
   Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
   Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23923.
   PubMed     Abstract available
   
   
   
3. NAZER RI, Albarrati AM
   The brain-before-heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single-institution experience.
   Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23913.
   PubMed     Abstract available
   
   
   
4. CHEN C, Li X, Su Y, You Z, et al
   Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence.
   Clin Cardiol. 2022 Sep 18. doi: 10.1002/clc.23898.
   PubMed     Abstract available
   
   
   
5. MANIAR Y, Blumenthal RS, Alfaddagh A
   The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.
   Clin Cardiol. 2022 Sep 10. doi: 10.1002/clc.23918.
   PubMed     Abstract available
   
   
   
6. YI M, Cao Q, Tang WH, Liu Q, et al
   Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
   Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23899.
   PubMed     Abstract available
   
   
   
7. YAO H, Guo Q, Cheng Y, Zhu T, et al
   Predictors and morphological properties of culprit healed plaques in patients with angina pectoris.
   Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23896.
   PubMed     Abstract available
   
   
   
8. VALENTINE CM, Chazal RA
   Essential nonclinical competencies for cardiovascular specialists imperatives for training.
   Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23914.
   PubMed     Abstract available
   
   
   
9. BRACEWELL NJ, Plasschaert J, Conti CR, Keeley EC, et al
   Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease.
   Clin Cardiol. 2022 Sep 2. doi: 10.1002/clc.23911.
   PubMed     Abstract available
   
   
   
10. YANG Y, Hong Y, Yang W, Zheng Z, et al
    Association of lipoprotein(a) with aortic dissection.
    Clin Cardiol. 2022;45:908-912.
    PubMed     Abstract available
    
    
    August 2022
11. SHARMA P, Shah K, Loomba J, Patel A, et al
    The impact of COVID-19 on clinical outcomes among acute myocardial infarction patients undergoing early invasive treatment strategy.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23908.
    PubMed     Abstract available
    
    
    
12. MOTAWEA KR, Gaber H, Singh RB, Swed S, et al
    Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23894.
    PubMed     Abstract available
    
    
    July 2022
13. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    PubMed     Abstract available
    
    
    
14. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available
    
    
    
15. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    PubMed     Abstract available
    
    
    June 2022
16. WU C, Bu R, Wang Y, Xu C, et al
    Rehabilitation effects of circuit resistance training in coronary heart disease patients: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23855.
    PubMed     Abstract available
    
    
    
17. LIMPIJANKIT T, Chandavimol M, Srimahachota S, Kanoksilp A, et al
    Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23877.
    PubMed     Abstract available
    
    
    
18. DE LUCA L, Calabro P, Chirillo F, Rolfo C, et al
    Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23878.
    PubMed     Abstract available
    
    
    
19. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed     Abstract available
    
    
    
20. WON KB, Park HB, Heo R, Lee BK, et al
    Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.
    Clin Cardiol. 2022 Jun 8. doi: 10.1002/clc.23870.
    PubMed     Abstract available
    
    
    
21. SCOTT C, Lateef SS, Hong CG, Dey AK, et al
    Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study.
    Clin Cardiol. 2022;45:622-628.
    PubMed     Abstract available
    
    
    
22. MIYATA K, Asano T, Saito A, Abe K, et al
    Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial.
    Clin Cardiol. 2022;45:605-613.
    PubMed     Abstract available
    
    
    May 2022
23. GAO L, Wang B, Cheng R
    Reply to comment on "Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis".
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23852.
    PubMed    
    
    
    
24. DENG JH, Zhang JX
    Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23851.
    PubMed    
    
    
    
25. YOU W, Zhou Y, Wu Z, Meng P, et al
    Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions.
    Clin Cardiol. 2022;45:558-566.
    PubMed     Abstract available
    
    
    April 2022
26. MOTAMED N, Ajdarkosh H, Karbalaie Niya MH, Panahi M, et al
    Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23827.
    PubMed     Abstract available
    
    
    March 2022
27. MA R, Gao J, Mao S, Wang Z, et al
    Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.
    Clin Cardiol. 2022 Mar 30. doi: 10.1002/clc.23818.
    PubMed     Abstract available
    
    
    
28. STOHR R, Dirrichs T, Kneizeh K, Reinartz S, et al
    Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
    Clin Cardiol. 2022 Mar 25. doi: 10.1002/clc.23819.
    PubMed     Abstract available
    
    
    
29. SUN M, Xing Y, Guo Y, Cao X, et al
    Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.
    Clin Cardiol. 2022 Mar 21. doi: 10.1002/clc.23815.
    PubMed     Abstract available
    
    
    
30. HOU J, Sun Y, Zhang L, Wang W, et al
    Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23811.
    PubMed     Abstract available
    
    
    
31. TOPPILA I, Ukkola-Vuoti L, Perttila J, Tornwall O, et al
    Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23814.
    PubMed     Abstract available
    
    
    
32. SUN L, Zhou M, Ji Y, Wang X, et al
    Off-pump versus on-pump coronary artery bypass grafting for octogenarians: A meta-analysis involving 146 372 patients.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23794.
    PubMed     Abstract available
    
    
    
33. LUPU L, Taha L, Banai A, Shmueli H, et al
    Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.
    Clin Cardiol. 2022 Mar 9. doi: 10.1002/clc.23781.
    PubMed     Abstract available
    
    
    
34. STEHLI J, Dinh D, Dagan M, Dick R, et al
    Sex differences in treatment and outcomes of patients with in-hospital ST-elevation myocardial infarction.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23797.
    PubMed     Abstract available
    
    
    
35. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    PubMed     Abstract available
    
    
    
36. WANG G, Zhao N, Zhong S, Wang H, et al
    Association of early repolarization pattern and ventricular fibrillation in patients with vasospastic angina: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23804.
    PubMed     Abstract available
    
    
    
37. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    PubMed     Abstract available
    
    
    February 2022
38. LEE P, Brennan A, Dinh D, Stub D, et al
    The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data.
    Clin Cardiol. 2022 Feb 22. doi: 10.1002/clc.23798.
    PubMed     Abstract available
    
    
    
39. KNOERY C, McEwan KA, Manktelow M, Watt J, et al
    Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficult.
    Clin Cardiol. 2022 Feb 8. doi: 10.1002/clc.23755.
    PubMed     Abstract available
    
    
    
40. VRSALOVIC M, Vrsalovic Presecki A, Aboyans V
    Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies.
    Clin Cardiol. 2022 Feb 7. doi: 10.1002/clc.23776.
    PubMed     Abstract available
    
    
    
41. ZHAO Y, Zhou P, Gao W, Zhong H, et al
    Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantation.
    Clin Cardiol. 2022 Feb 4. doi: 10.1002/clc.23787.
    PubMed     Abstract available
    
    
    
42. KATIKIREDDY CK, Samim A
    Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Clin Cardiol. 2022;45:152-161.
    PubMed     Abstract available
    
    
    January 2022
43. XU J, Chen X, Xie Y, Lin J, et al
    Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury.
    Clin Cardiol. 2022 Jan 30. doi: 10.1002/clc.23785.
    PubMed     Abstract available
    
    
    
44. LIN XL, Sun HX, Li FQ, Zhao JY, et al
    Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23749.
    PubMed     Abstract available
    
    
    
45. SANG DS, Zhang Q, Song D, Tao J, et al
    Association between brachial-ankle pulse wave velocity and cardiovascular and cerebrovascular disease in different age groups.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23777.
    PubMed     Abstract available
    
    
    
46. YANG L, Zhu H, Sun Y, Yan P, et al
    Value of M2BP in predicting in-stent restenosis in patients after coronary drug-eluting stent implantation.
    Clin Cardiol. 2022 Jan 15. doi: 10.1002/clc.23775.
    PubMed     Abstract available
    
    
    
47. CHI G, Lee JJ, Kazmi SHA, Fitzgerald C, et al
    Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design.
    Clin Cardiol. 2022 Jan 12. doi: 10.1002/clc.23773.
    PubMed     Abstract available
    
    
    
48. QIN Q, Chen L, Ge L, Qian J, et al
    A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23771.
    PubMed     Abstract available
    
    
    
49. SHI Y, He S, Luo J, Jian W, et al
    Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery: A meta-analysis.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23766.
    PubMed     Abstract available
    
    
    December 2021
50. ZHANG M, Zuo HJ, Yang HX, Nan N, et al
    Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction.
    Clin Cardiol. 2021 Dec 28. doi: 10.1002/clc.23770.
    PubMed     Abstract available
    
    
    
51. DALLI PEYDRO E, Sanz Sevilla N, Tuzon Segarra MT, Miro Palau V, et al
    A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.
    Clin Cardiol. 2021 Dec 24. doi: 10.1002/clc.23757.
    PubMed     Abstract available
    
    
    November 2021
52. DISSANAYAKE HU, Colpani JT, Sutherland K, Loke W, et al
    Obstructive sleep apnea therapy for cardiovascular risk reduction-Time for a rethink?
    Clin Cardiol. 2021 Nov 17. doi: 10.1002/clc.23747.
    PubMed     Abstract available
    
    
    
53. XING Z, Wang X, Pei J, Zhu Z, et al
    The association of interferon-alpha with development of collateral circulation after artery occlusion.
    Clin Cardiol. 2021;44:1621-1627.
    PubMed     Abstract available
    
    
    October 2021
54. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    PubMed     Abstract available
    
    
    
55. HOFER F, Kazem N, Schweitzer R, Horvat P, et al
    The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
    Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23741.
    PubMed     Abstract available
    
    
    
56. GONG Y, Li X, Ma X, Yu H, et al
    Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
    Clin Cardiol. 2021 Oct 15. doi: 10.1002/clc.23725.
    PubMed     Abstract available
    
    
    
57. MOHAMED A
    Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
    Clin Cardiol. 2021;44:1371-1376.
    PubMed     Abstract available
    
    
    September 2021
58. LIMPIJANKIT T, Vathesatogkit P, Matchariyakul D, Yingchoncharoen T, et al
    Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23735.
    PubMed     Abstract available
    
    
    
59. CHEN G, Farris MS, Cowling T, Pinto L, et al
    Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23732.
    PubMed     Abstract available
    
    
    
60. PACHECO C, Wei J, Shufelt C, C Hitzeman T, et al
    Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Clin Cardiol. 2021 Sep 16. doi: 10.1002/clc.23726.
    PubMed     Abstract available
    
    
    
61. Y-HASSAN S, Sorensson P, Ekenback C, Lundin M, et al
    Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study.
    Clin Cardiol. 2021 Sep 7. doi: 10.1002/clc.23723.
    PubMed     Abstract available
    
    
    
62. ZHANG FW, Zhang YX, Si LY, Chen MS, et al
    Value of acoustic cardiography in the clinical diagnosis of coronary heart disease.
    Clin Cardiol. 2021 Sep 5. doi: 10.1002/clc.23694.
    PubMed     Abstract available
    
    
    
63. GRINBERG T, Bental T, Hammer Y, Assali A, et al
    Management and outcome across the spectrum of high-risk patients with myocardial infarction according to the thrmobolysis in myocardial infarction (TIMI) risk-score for secondary prevention.
    Clin Cardiol. 2021 Sep 1. doi: 10.1002/clc.23715.
    PubMed     Abstract available
    
    
    August 2021
64. ZHAO J, Zeng Y, Shen X
    Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis.
    Clin Cardiol. 2021 Aug 31. doi: 10.1002/clc.23717.
    PubMed     Abstract available
    
    
    
65. SHUI X, Wen Z, Chen Z, Xie X, et al
    Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease.
    Clin Cardiol. 2021 Aug 25. doi: 10.1002/clc.23718.
    PubMed     Abstract available
    
    
    
66. DUFFY EY, Ashen D, Blumenthal RS, Davis DM, et al
    Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention.
    Clin Cardiol. 2021 Aug 20. doi: 10.1002/clc.23555.
    PubMed     Abstract available
    
    
    
67. WELSH RC, Shavadia JS, Zheng Y, Tyrrell BD, et al
    Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST-segment elevation myocardial infarction.
    Clin Cardiol. 2021 Aug 18. doi: 10.1002/clc.23716.
    PubMed     Abstract available
    
    
    
68. LESEN E, Hewitt C, Giannitsis E, Hedberg J, et al
    Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study.
    Clin Cardiol. 2021 Aug 8. doi: 10.1002/clc.23702.
    PubMed     Abstract available
    
    
    
69. FONAROW GC, Kosiborod MN, Rane PB, Nunna S, et al
    Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease.
    Clin Cardiol. 2021 Aug 5. doi: 10.1002/clc.23706.
    PubMed     Abstract available
    
    
    
70. BERMAN AN, Biery DW, Ginder C, Hulme OL, et al
    Natural language processing for the assessment of cardiovascular disease comorbidities: The cardio-Canary comorbidity project.
    Clin Cardiol. 2021 Aug 4. doi: 10.1002/clc.23687.
    PubMed     Abstract available
    
    
    
71. KIM YK, Jang CW, Kwon SH, Kim JH, et al
    Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion.
    Clin Cardiol. 2021;44:1161-1168.
    PubMed     Abstract available
    
    
    July 2021
72. CUI YK, Dong JZ, Du X, Hu R, et al
    Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort study.
    Clin Cardiol. 2021 Jul 28. doi: 10.1002/clc.23699.
    PubMed     Abstract available
    
    
    
73. ULLAH H, Elakabawi K, Ke H, Ullah N, et al
    Predictors and 3-year outcomes of compromised left circumflex coronary artery after left main crossover stenting.
    Clin Cardiol. 2021 Jul 16. doi: 10.1002/clc.23693.
    PubMed     Abstract available
    
    
    
74. VON KANEL R, Pazhenkottil AP, Meister-Langraf RE, Znoj H, et al
    Longitudinal association between cognitive depressive symptoms and D-dimer levels in patients following acute myocardial infarction.
    Clin Cardiol. 2021 Jul 7. doi: 10.1002/clc.23689.
    PubMed     Abstract available
    
    
    
75. HANSON CA, Lu E, Ghumman SS, Ouellette ML, et al
    Long-term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography.
    Clin Cardiol. 2021 Jul 3. doi: 10.1002/clc.23686.
    PubMed     Abstract available
    
    
    
76. TANG J, Hou H, Chu J, Chen F, et al
    Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Clin Cardiol. 2021;44:978-986.
    PubMed     Abstract available
    
    
    June 2021
77. CHEN Y, Chen Y, Wen F, He Z, et al
    Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta-analysis.
    Clin Cardiol. 2021 Jun 19. doi: 10.1002/clc.23669.
    PubMed     Abstract available
    
    
    
78. DANNENBERG V, Christiansen F, Schneider M, Kastl S, et al
    Exploratory echocardiographic strain parameters for the estimation of myocardial infarct size in ST-elevation myocardial infarction.
    Clin Cardiol. 2021 Jun 12. doi: 10.1002/clc.23608.
    PubMed     Abstract available
    
    
    
79. BLANCHART K, Heudel T, Ardouin P, Lemaitre A, et al
    Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre-treated with newer P2Y12 inhibitors.
    Clin Cardiol. 2021 Jun 11. doi: 10.1002/clc.23654.
    PubMed     Abstract available
    
    
    
80. RAYNER-HARTLEY E, Wong GC, Fayowski C, Cairns JA, et al
    Impact of regionalizing ST-elevation myocardial infarction care on sex differences in reperfusion times and clinical outcomes.
    Clin Cardiol. 2021 Jun 8. doi: 10.1002/clc.23658.
    PubMed     Abstract available
    
    
    
81. XIE Q, Huang J, Zhu K, Chen Q, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.
    Clin Cardiol. 2021 Jun 5. doi: 10.1002/clc.23613.
    PubMed     Abstract available
    
    
    
82. NAVAR AM, Matskeplishvili ST, Urina-Triana M, Arafah M, et al
    Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries.
    Clin Cardiol. 2021 Jun 5. doi: 10.1002/clc.23623.
    PubMed     Abstract available
    
    
    
83. LIANG J, Zhang J, Xu Y, Teng C, et al
    Conventional cardiovascular risk factors associated with Takotsubo cardiomyopathy: A comprehensive review.
    Clin Cardiol. 2021 Jun 3. doi: 10.1002/clc.23661.
    PubMed     Abstract available
    
    
    
84. KUEHNEMUND L, Koeppe J, Feld J, Wiederhold A, et al
    Gender differences in acute myocardial infarction-A nationwide German real-life analysis from 2014 to 2017.
    Clin Cardiol. 2021 Jun 1. doi: 10.1002/clc.23662.
    PubMed     Abstract available
    
    
    
85. GAO S, Ma W, Huang S, Lin X, et al
    Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries.
    Clin Cardiol. 2021 Jun 1. doi: 10.1002/clc.23650.
    PubMed     Abstract available
    
    
    May 2021
86. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    PubMed     Abstract available
    
    
    
87. TOMER O, Leibowitz D, Einhorn-Cohen M, Shlomo N, et al
    The impact of short hospital stay on prognosis after acute myocardial infarction: An analysis from the ACSIS database.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23652.
    PubMed     Abstract available
    
    
    
88. MENG Z, Yang J, Wu J, Zheng X, et al
    Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23648.
    PubMed     Abstract available
    
    
    
89. LAM ASM, Yan BPY, Lee VWY
    Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post-acute coronary syndrome patients-A 10-year cohort study.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23653.
    PubMed     Abstract available
    
    
    
90. EGGERS KM, Baron T, Hjort M, Nordenskjold AM, et al
    Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23651.
    PubMed     Abstract available
    
    
    
91. KAIHARA T, Higuma T, Izumo M, Kotoku N, et al
    Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23655.
    PubMed     Abstract available
    
    
    
92. ROBERTS R, Fair J
    Genetics, its role in preventing the pandemic of coronary artery disease.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23627.
    PubMed     Abstract available
    
    
    
93. WANG SJ, Zhao HY, Fan XT
    Reply to the Letter to the Editor Entitled "Optimal risk stratification and therapeutic strategy for acute myocardial infarction".
    Clin Cardiol. 2021 May 22. doi: 10.1002/clc.23646.
    PubMed    
    
    
    
94. IMAMURA T
    Optimal risk stratification and therapeutic strategy for acute myocardial infarction.
    Clin Cardiol. 2021 May 20. doi: 10.1002/clc.23645.
    PubMed    
    
    
    
95. GAO L, Wang B, Pan Y, Lu Y, et al
    Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
    Clin Cardiol. 2021 May 20. doi: 10.1002/clc.23643.
    PubMed     Abstract available
    
    
    
96. LOWENSTERN A, Li S, Navar AM, Virani SS, et al
    Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry.
    Clin Cardiol. 2021 May 18. doi: 10.1002/clc.23625.
    PubMed     Abstract available
    
    
    
97. PATEL A, Goodman SG, Tan M, Suskin N, et al
    Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study.
    Clin Cardiol. 2021 May 13. doi: 10.1002/clc.23618.
    PubMed     Abstract available
    
    
    
98. LI Q, Chen Y, Liu Y, Yu L, et al
    Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel.
    Clin Cardiol. 2021 May 12. doi: 10.1002/clc.23588.
    PubMed     Abstract available
    
    
    
99. WEN Y, Yang Y, Shen J, Luo S, et al
    Anxiety and prognosis of patients with myocardial infarction: A meta-analysis.
    Clin Cardiol. 2021 May 7. doi: 10.1002/clc.23605.
    PubMed     Abstract available
    
    
    
100. IMAMURA T
     Clinical implication of coronary artery calcium score.
     Clin Cardiol. 2021 May 6. doi: 10.1002/clc.23614.
     PubMed    
     
     
     
101. GHODSI S, Mohebi M, Sadre-Bafghi SA, Poorhosseini H, et al
     Prognostic implications of calculated Apo-lipoprotein B in patients with segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut-points.
     Clin Cardiol. 2021 May 4. doi: 10.1002/clc.23610.
     PubMed     Abstract available
     
     
     March 2021
102. WANG X, Pei J, Zheng K, Hu X, et al
     High-density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension.
     Clin Cardiol. 2021 Mar 30. doi: 10.1002/clc.23606.
     PubMed     Abstract available
     
     
     
103. WANG SJ, Cheng ZX, Fan XT, Lian YG, et al
     Development of an optimized risk score to predict short-term death among acute myocardial infarction patients in rural China.
     Clin Cardiol. 2021 Mar 25. doi: 10.1002/clc.23598.
     PubMed     Abstract available
     
     
     
104. SAVITZ ST, Falk K, Stearns SC, Grove L, et al
     Coronary revascularization outcomes in relation to skilled nursing facility use following hospital discharge.
     Clin Cardiol. 2021 Mar 23. doi: 10.1002/clc.23583.
     PubMed     Abstract available
     
     
     
105. VIJ A, Kassab K, Chawla H, Kaur A, et al
     Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis.
     Clin Cardiol. 2021 Mar 20. doi: 10.1002/clc.23592.
     PubMed     Abstract available
     
     
     
106. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
     Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
     Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
     PubMed     Abstract available
     
     
     
107. XU Y, Ye H, Zhu Y, Du S, et al
     The efficacy of mobile health in alleviating risk factors related to the occurrence and development of coronary heart disease: A systematic review and meta-analysis.
     Clin Cardiol. 2021 Mar 16. doi: 10.1002/clc.23596.
     PubMed     Abstract available
     
     
     
108. CHEN W, Zhang C, Zhao J, Xu X, et al
     Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis.
     Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23536.
     PubMed     Abstract available
     
     
     
109. LIU T, Liu J, Wu Z, Lv Y, et al
     Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography.
     Clin Cardiol. 2021 Mar 9. doi: 10.1002/clc.23565.
     PubMed     Abstract available
     
     
     
110. RAO VN, Kelsey MD, Kelsey AM, Russell SD, et al
     Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic.
     Clin Cardiol. 2021 Mar 7. doi: 10.1002/clc.23590.
     PubMed     Abstract available
     
     
     
111. NAGUMO S, Collet C, Norgaard BL, Otake H, et al
     Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography-based percutaneous intervention planner.
     Clin Cardiol. 2021 Mar 3. doi: 10.1002/clc.23551.
     PubMed     Abstract available
     
     
     
112. BRISCOE M, Sykes R, Krystofiak T, Peck O, et al
     Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury.
     Clin Cardiol. 2021;44:332-339.
     PubMed     Abstract available
     
     
     
113. KONIGSTEIN M, Ponticelli F, Zivelonghi C, Merdler I, et al
     Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
     Clin Cardiol. 2021;44:424-428.
     PubMed     Abstract available
     
     
     February 2021
114. CHEN Z, Wang D, Ma M, Li C, et al
     Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
     Clin Cardiol. 2021 Feb 25. doi: 10.1002/clc.23582.
     PubMed     Abstract available
     
     
     
115. ABULIMITI A, Nishitani-Yokoyama M, Shimada K, Kunimoto M, et al
     Prognostic impact of peak oxygen uptake and heart rate reserve in patients after off-pump coronary artery bypass grafting.
     Clin Cardiol. 2021 Feb 25. doi: 10.1002/clc.23579.
     PubMed     Abstract available
     
     
     
116. YANG T, Fu X, Fu P, Chen J, et al
     The value of fragmented QRS in predicting the prognosis of chronic total occlusion patients with myocardial infarction history undergoing percutaneous coronary intervention: A 24-months follow-up study.
     Clin Cardiol. 2021 Feb 16. doi: 10.1002/clc.23573.
     PubMed     Abstract available
     
     
     
117. SYKES R, Mohamed MO, Kwok CS, Mamas MA, et al
     Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).
     Clin Cardiol. 2021 Feb 16. doi: 10.1002/clc.23543.
     PubMed     Abstract available
     
     
     
118. PUYMIRAT E, Nakache A, Saint Etienne C, Marcollet P, et al
     Is coronary multivessel disease in acute myocardial infarction patients still associated with worse clinical outcomes at 1-year?
     Clin Cardiol. 2021 Feb 14. doi: 10.1002/clc.23567.
     PubMed     Abstract available
     
     
     
119. WU TT, Lin XQ, Mu Y, Li H, et al
     Machine learning for early prediction of in-hospital cardiac arrest in patients with acute coronary syndromes.
     Clin Cardiol. 2021 Feb 14. doi: 10.1002/clc.23541.
     PubMed     Abstract available
     
     
     
120. HUANG W, Lim LMH, Aurangzeb AS, Wong CJ, et al
     Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification.
     Clin Cardiol. 2021;44:267-275.
     PubMed     Abstract available
     
     
     January 2021
121. KONIG S, Ueberham L, Pellissier V, Hohenstein S, et al
     Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network.
     Clin Cardiol. 2021 Jan 26. doi: 10.1002/clc.23549.
     PubMed     Abstract available
     
     
     
122. LIU Q, Gao X, Xiao Q, Zhu B, et al
     A combination of NLR and sST2 is associated with adverse cardiovascular events in patients with myocardial injury induced by moderate to severe acute carbon monoxide poisoning.
     Clin Cardiol. 2021 Jan 26. doi: 10.1002/clc.23550.
     PubMed     Abstract available
     
     
     
123. CEPAS-GUILLEN PL, Echarte-Morales J, Flores-Umanzor E, Fernandez-Valledor A, et al
     Sex-gender disparities in nonagenarians with acute coronary syndrome.
     Clin Cardiol. 2021 Jan 19. doi: 10.1002/clc.23545.
     PubMed     Abstract available
     
     
     
124. LIN Z, Han H, Qin Y, Zhang Y, et al
     Outcomes after readmission at the index or nonindex hospital following acute myocardial infarction complicated by cardiogenic shock.
     Clin Cardiol. 2021 Jan 7. doi: 10.1002/clc.23526.
     PubMed     Abstract available
     
     
     
125. SHI X, Zhu T, Ni J, Zhang R, et al
     The expression of myeloperoxidase in thrombi is associated with reduced heme oxygenase-1 induction and worse left ventricular remodeling in patients with acute ST-elevation myocardial infarction.
     Clin Cardiol. 2021 Jan 6. doi: 10.1002/clc.23542.
     PubMed     Abstract available
     
     
     
126. DUCROCQ G, Calvo G, Gonzalez-Juanatey JR, Durand-Zaleski I, et al
     Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial.
     Clin Cardiol. 2021 Jan 6. doi: 10.1002/clc.23453.
     PubMed     Abstract available
     
     
     
127. WU E, Martensson J, Desta L, Brostrom A, et al
     Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris.
     Clin Cardiol. 2021 Jan 5. doi: 10.1002/clc.23516.
     PubMed     Abstract available
     
     
     December 2020
128. TANAKA T, Miki K, Akahori H, Imanaka T, et al
     Comparison of coronary atherosclerotic disease burden between ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: Non-culprit Gensini score and non-culprit SYNTAX score.
     Clin Cardiol. 2020 Dec 28. doi: 10.1002/clc.23534.
     PubMed     Abstract available
     
     
     
129. CUI C, Sheng Z
     Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: A systematic review and meta-analysis.
     Clin Cardiol. 2020 Dec 17. doi: 10.1002/clc.23524.
     PubMed     Abstract available
     
     
     
130. WANG Y, Jiang Y, Zhi W, Fu Y, et al
     Safety and feasibility of low-dose ticagrelor in patients with ST-segment elevation myocardial infarction.
     Clin Cardiol. 2020 Dec 15:e23517. doi: 10.1002/clc.23517.
     PubMed     Abstract available
     
     
     
131. YAZAKI M, Nabeta T, Inomata T, Maemura K, et al
     Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study.
     Clin Cardiol. 2020 Dec 9. doi: 10.1002/clc.23529.
     PubMed     Abstract available
     
     
     
132. ANYANWU EC, Chua RFM, Besser SA, Sun D, et al
     SALAD-BAAR: A Numerical Risk Score for Hospital Admission or Emergency Department Presentation in Ambulatory Patients with Cardiovascular Disease.
     Clin Cardiol. 2020 Dec 5. doi: 10.1002/clc.23525.
     PubMed     Abstract available
     
     
     
133. DARMON A, Ducrocq G, Jasilek A, Feldman L, et al
     Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry.
     Clin Cardiol. 2020 Dec 4. doi: 10.1002/clc.23505.
     PubMed     Abstract available
     
     
     
134. HUANG Z, Shui X, Ling Y, Zhou L, et al
     Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
     Clin Cardiol. 2020 Dec 2. doi: 10.1002/clc.23520.
     PubMed     Abstract available
     
     
     November 2020
135. XIE C, Hang Y, Zhu J, Li C, et al
     Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta-analysis.
     Clin Cardiol. 2020 Nov 21. doi: 10.1002/clc.23514.
     PubMed     Abstract available
     
     
     
136. SHI W, Ni L, Yang J, Fan X, et al
     Appropriateness of gastrointestinal prophylaxis use during hospitalization in patients with acute myocardial infarction: Analysis from the China Acute Myocardial Infarction Registry.
     Clin Cardiol. 2020 Nov 19. doi: 10.1002/clc.23449.
     PubMed     Abstract available
     
     
     
137. KAWAMURA Y, Yokoyama H, Kitayama K, Miura N, et al
     Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.
     Clin Cardiol. 2020 Nov 12. doi: 10.1002/clc.23510.
     PubMed     Abstract available
     
     
     
138. JOHANSEN ME, Argyropoulos C
     The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now.
     Clin Cardiol. 2020 Nov 9. doi: 10.1002/clc.23508.
     PubMed     Abstract available
     
     
     
139. SHAHANDEH N, Dai X, Jaski B, Dave R, et al
     Mortality differences among patients with in-hospital ST-elevation myocardial infarction.
     Clin Cardiol. 2020 Nov 7. doi: 10.1002/clc.23480.
     PubMed     Abstract available
     
     
     
140. NICOLAU JC, Brieger D, Owen R, Furtado RHM, et al
     Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction.
     Clin Cardiol. 2020 Nov 4. doi: 10.1002/clc.23476.
     PubMed     Abstract available
     
     
     October 2020
141. KORNEJ J, Henger S, Seewoster T, Teren A, et al
     Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE-Heart Study.
     Clin Cardiol. 2020 Oct 27. doi: 10.1002/clc.23490.
     PubMed     Abstract available
     
     
     
142. LIU M, Deng C, Yuan P, Ma J, et al
     Anxiety, depression, and medication adherence in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease.
     Clin Cardiol. 2020 Oct 26. doi: 10.1002/clc.23495.
     PubMed    
     
     
     
143. CHENG YJ, Zhao XX, Pan SP, Pan JM, et al
     Association of early repolarization pattern with cardiovascular outcomes in middle-aged population: A cohort study.
     Clin Cardiol. 2020 Oct 26. doi: 10.1002/clc.23488.
     PubMed     Abstract available
     
     
     
144. LOW TT, Houdmont M, Sim HW, Chan KH, et al
     Spontaneous coronary artery dissection: clinical implications and diagnostic challenges. Overlooked and underappreciated in Asia?
     Clin Cardiol. 2020 Oct 20. doi: 10.1002/clc.23484.
     PubMed     Abstract available
     
     
     
145. BORTNICK AE, Shahid M, Shitole SG, Park M, et al
     Outcomes of ST-elevation myocardial infarction by age and sex in a low-income urban community: The Montefiore STEMI Registry.
     Clin Cardiol. 2020;43:1100-1109.
     PubMed     Abstract available
     
     
     April 2020
146. WANG G, Zheng W, Wu S, Ma J, et al
     Comparison of usual care and the HEART score for effectively and safely discharging patients with low-risk chest pain in the emergency department: would the score always help?
     Clin Cardiol. 2020;43:371-378.
     PubMed     Abstract available
     
     
     January 2020
147. TIAN Z, Li T, Ma S
     Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A meta-analysis.
     Clin Cardiol. 2020 Jan 20. doi: 10.1002/clc.23331.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: